USE OF RECOMBINANT HUMAN TSH IN THYROID CANCER PATIENTS
USE OF RECOMBINANT HUMAN TSH IN THYROID CANCER PATIENTS
批准号:
6123214
负责人:
ANDREA MANNI
金额:
$3.26万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30
中文摘要
目前,高分化甲状腺癌患者在接受了近全甲状腺切除术后,如果发现甲状腺残留和/或转移,通常要接受全身I131扫描和I131治疗。在这些治疗之前,护理标准要求停止甲状腺激素替代,以刺激内源性TSH分泌,以优化残留甲状腺组织和/或转移灶对I131的摄取。对于患有充血性心力衰竭等疾病的患者来说,这种方法可能是危险的,长期的甲状腺功能减退状态可能会对患者产生不利影响。本研究的目的是为甲状腺癌患者在接受甲状腺扫描之前注射重组TSH(甲状腺激素),以避免长期的甲状腺功能低下,以指导和治疗残留的甲状腺癌。作为重组技术的产物,Thrygen可以支持TSH依赖的代谢活性,而不被认为是抗原性实体。到目前为止,已经有两名患者根据这一方案成功地接受了胸腺激素治疗。两组均未出现任何不良反应,且两组均可在全身扫描和I131治疗中显示残留和/或转移的甲状腺组织。
英文摘要
At the present time, patients with well differentiated thyroid cancer who have undergone a near total thyroidectomy are frequently subjected to a total body I131 scan and I131 treatment if thyroid remnants and/or metastasis are identified on the scan. Prior to these treatments, the standard of care requires withdrawal of thyroid hormone replacement to stimulate endogenous TSH secretion needed to optimize I131 uptake by residual thyroid tissue and/or metastasis. This approach may be hazardous in patients with medical conditions such as congestive heart failures, which may be adversely affected by a prolonged state of hypothyroidism. The purpose of this study is to offer patients with thyroid cancer an injection of recombinant TSH (Thyrogen) to avoid prolonged hypothyroidism prior to obtaining a thyroid scan for the direction and treatment of residual thyroid cancer. As a product of recombinant technology, Thryrogen could support TSH-dependent metabolic activities without being recognized as an antigenic entity. Until now, two patients have been successfully treated with thyrogen according to this protocol. Neither experienced any adverse reaction and in both thyrogen administration allowed visualization of residual and/or metastatic thyroid tissue on total body scan and treatment with I131.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Polyamines and Breast Cancer Biology
-
批准号:6889591
-
项目类别:
-
资助金额:$31.76万
-
财政年份:2003
-
负责人:ANDREA MANNI
-
依托单位:
Polyamines and Breast Cancer Biology
-
批准号:6683892
-
项目类别:
-
资助金额:$30.71万
-
财政年份:2003
-
负责人:ANDREA MANNI
-
依托单位:
Polyamines and Breast Cancer Biology
-
批准号:6764091
-
项目类别:
-
资助金额:$30.84万
-
财政年份:2003
-
负责人:ANDREA MANNI
-
依托单位:
POLYAMINE INVOLVEMENT IN MAMMARY CARCINOGENESIS
-
批准号:2624295
-
项目类别:
-
资助金额:$22.62万
-
财政年份:1998
-
负责人:ANDREA MANNI
-
依托单位:
POLYAMINE INVOLVEMENT IN MAMMARY CARCINOGENESIS
-
批准号:2871918
-
项目类别:
-
资助金额:$23.18万
-
财政年份:1998
-
负责人:ANDREA MANNI
-
依托单位:
POLYAMINE INVOLVEMENT IN MAMMARY CARCINOGENESIS
-
批准号:6350208
-
项目类别:
-
资助金额:$24.36万
-
财政年份:1998
-
负责人:ANDREA MANNI
-
依托单位:
POLYAMINE INVOLVEMENT IN MAMMARY CARCINOGENESIS
-
批准号:6150241
-
项目类别:
-
资助金额:$23.76万
-
财政年份:1998
-
负责人:ANDREA MANNI
-
依托单位:
USE OF RECOMBINANT HUMAN TSH IN THYROID CANCER PATIENTS
-
批准号:6283096
-
项目类别:
-
资助金额:$2.16万
-
财政年份:1997
-
负责人:ANDREA MANNI
-
依托单位:
ROLE OF POLYAMINES IN BREAST TUMOR MITOGENESIS
-
批准号:6102215
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1995
-
负责人:ANDREA MANNI
-
依托单位:
A-DIFLUOROMETHYLORNITHINE IN PATIENTS WITH ADVANCED BREAST CANCER
-
批准号:6286808
-
项目类别:
-
资助金额:$3.26万
-
财政年份:1995
-
负责人:ANDREA MANNI
-
依托单位:
ROLE OF IGFS AND THEIR BINDING PROTEINS IN THE GROWTH OF BREAST CANCER
-
批准号:6102219
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1995
-
负责人:ANDREA MANNI
-
依托单位:
MITOTIC MODIFIERS OF HORMONE-DEPENDENT BREAST CANCER
-
批准号:3093739
-
项目类别:
-
资助金额:$99.92万
-
财政年份:1985
-
负责人:ANDREA MANNI
-
依托单位:
MITOTIC MODIFIERS OF HORMONE-DEPENDENT BREAST CANCER
-
批准号:2090062
-
项目类别:
-
资助金额:$99.64万
-
财政年份:1985
-
负责人:ANDREA MANNI
-
依托单位:
CLINICAL CORRELATES OF BIOLOGIC FACTORS IN BREAST CANCER
-
批准号:2090060
-
项目类别:
-
资助金额:$3.28万
-
财政年份:1985
-
负责人:ANDREA MANNI
-
依托单位:
MITOTIC MODIFIERS OF HORMONE-DEPENDENT BREAST CANCER
-
批准号:2090059
-
项目类别:
-
资助金额:$79.83万
-
财政年份:1985
-
负责人:ANDREA MANNI
-
依托单位:
ENDOCRINE DETERMINANTS OF BREAST CANCER
-
批准号:4691651
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ANDREA MANNI
-
依托单位:
HORMONE STIMULATION PLUS CHEMOTHERAPY IN BREAST AND PROSTATE CANCER
-
批准号:4691650
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ANDREA MANNI
-
依托单位:
NOLVADEX TAMOXIFEN IN BREAST CARCINOMA TREATMENT
-
批准号:4700418
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ANDREA MANNI
-
依托单位:
海外基金